| Dr Syed Moinuddin Jilani, MD | |
|
3285 Skypark Dr, Torrance, CA 90505-5004 | |
| (310) 750-3300 | |
| (310) 750-3381 |
| Full Name | Dr Syed Moinuddin Jilani |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 34 Years |
| Location | 3285 Skypark Dr, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629067442 | NPI | - | NPPES |
| 830008109 | Other | RAILROAD MEDICARE | |
| 00A54321 | Other | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A54321 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Providence Little Company Of Mary Med Ctr Torrance | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Torrance Health Association Inc | 1355302134 | 249 |
News Archive
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center's kidney cancer program. The study, published in the International Journal of Radiation Oncology*Biology*Physics, could offer new hope for patients with a historically dismal condition.
An innovative new Consortium will act as a ‘match-making' service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options.
Early detection of the most common form of epilepsy in children is possible through "deep learning," a new machine learning tool that teaches computers to learn by example, according to a new study that includes researchers from Georgia State University.
› Verified 7 days ago
| Entity Name | Torrance Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083903124 PECOS PAC ID: 1355302134 Enrollment ID: O20110819000276 |
News Archive
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center's kidney cancer program. The study, published in the International Journal of Radiation Oncology*Biology*Physics, could offer new hope for patients with a historically dismal condition.
An innovative new Consortium will act as a ‘match-making' service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options.
Early detection of the most common form of epilepsy in children is possible through "deep learning," a new machine learning tool that teaches computers to learn by example, according to a new study that includes researchers from Georgia State University.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Syed Moinuddin Jilani, MD 3285 Skypark Dr, Torrance, CA 90505-5004 Ph: (310) 750-3300 | Dr Syed Moinuddin Jilani, MD 3285 Skypark Dr, Torrance, CA 90505-5004 Ph: (310) 750-3300 |
News Archive
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center's kidney cancer program. The study, published in the International Journal of Radiation Oncology*Biology*Physics, could offer new hope for patients with a historically dismal condition.
An innovative new Consortium will act as a ‘match-making' service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options.
Early detection of the most common form of epilepsy in children is possible through "deep learning," a new machine learning tool that teaches computers to learn by example, according to a new study that includes researchers from Georgia State University.
› Verified 7 days ago
Deborah Chon, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |